For years, obesity was treated as a downstream issue that was addressed episodically, and often framed as an individual problem rather than a chronic condition with significant financial, clinical, and workforce implications. GLP-1s changed that almost overnight.
As the conversation evolves, employers are increasingly taking a broader, more strategic view of obesity management and metabolic health. That evolution is placing benefits consultants at the center of one of the most important healthcare strategy conversations facing employers today. And the urgency is impossible to ignore.
In a market where 9 out of 10 U.S. employees have at least one cardiometabolic risk factor, employers are recognizing that there is a critical space between traditional wellness programs and high-cost disease management called preventive intervention.
That is where organizations increasingly need strategic guidance.
Employers are asking difficult questions with no easy answers:
- How do we balance access, affordability, and long-term sustainability?
- What does responsible GLP-1 stewardship actually look like?
- How much future financial exposure are we creating?
- What happens when utilization accelerates faster than budgets?
- How do we support employees without turning obesity strategy into a pharmacy-only conversation?
At the same time, consultants are navigating enormous pressure from multiple directions:
- CFOs demanding cost predictability
- CHROs focused on employee experience and equity
- PBMs and point solutions competing to define the strategy
- Rapidly evolving clinical guidance
- Mounting skepticism around ROI claims
The market is moving faster than most organizations can build durable strategies around it.
And that is creating a dangerous dynamic: many employers are making long-term obesity benefit decisions based on short-term urgency.
The GLP-1 Conversation Is Too Narrow
One of the biggest risks in today’s market is that obesity strategy is becoming synonymous with medication strategy. That framing may simplify procurement conversations, but it oversimplifies obesity itself.
GLP-1s are clinically important tools. But effective strategies also increasingly incorporate approaches that reduce weight stigma and support individuals through behavior change in a way that reflects biological, environmental, and lived experience factors not willpower alone.
For many individuals, they can be transformative. But employers are increasingly discovering that medication access alone does not solve the broader challenges they are trying to address:
- Long-term adherence
- Weight regain after discontinuation
- Sustainable behavior change
- Cardiometabolic risk reduction
- Workforce productivity
- Total cost of care management
The organizations seeing the greatest success are shifting away from viewing GLP-1s as a standalone solution and toward a more integrated obesity strategy that combines:
- Behavioral support
- GLP-1 governance
- Engagement science
- Population health management
- Cost management discipline
- Flexible funding models
This is why preventive intervention matters so much.
The most effective obesity strategies are not waiting until risk becomes chronic disease spend. They are targeting cardiometabolic health factors upstream and helping prevent manageable risk from becoming unstoppable spend.
That shift represents an important opportunity for benefits consultants.
The consultants who lead in this next phase of the market will not simply help employers decide whether to cover GLP-1s. They will help employers build frameworks for managing obesity as a long-term population health strategy.
Why Consultant Credibility Matters More Than EverAs GLP-1 spending rises, so does executive scrutiny.
C-suites are increasingly asking whether recommendations are being shaped by outcomes, by utilization incentives, or by market momentum. In response, consultants are facing a new kind of reputational challenge: not just recommending solutions, but defending the integrity of the strategy itself.
This is why independence matters more than ever.
In a crowded obesity benefits market, employers need guidance that is perceived as objective, evidence-based, and grounded in long-term value, not simply utilization growth or pharmaceutical economics.
That means moving beyond narrow definitions of “weight management” toward approaches that recognize that well-being is shaped by biology, environment, and lived experience, not willpower alone, and ensuring strategies reduce bias in how weight and health are understood while creating more supportive pathways to care.
That is one reason organizations are increasingly looking for partners like Wondr Health, whose science-backed behavioral foundation is designed around sustainable outcomes, metabolic health improvement, and responsible GLP-1 governance, not drug-driven incentives alone.
Wondr Health’s future-ready approach reflects where the market is heading: integrated obesity and GLP-1 management solutions that can operate as standalone programs or integrate with broader benefits ecosystems, while giving employers flexibility around funding models, access strategies, and long-term governance.
Independence is no longer a marketing differentiator. It is becoming a strategic requirement.
The Next Competitive Advantage for Consultants: Predictability
Historically, employers tolerated a certain degree of variability in healthcare spend. GLP-1s are changing that equation because the potential scale and duration of utilization create a level of financial exposure many organizations have never modeled before.
What employers want now is not simply cost reduction. They want predictability.
That changes the role consultants play.
The most valuable consultants in the next several years will be those who can help employers:
- Model long-term utilization scenarios
- Evaluate sustainable access strategies
- Connect obesity management to total cost of care
- Distinguish between engagement metrics and meaningful outcomes
- Build strategies resistant to future market changes
In other words, the consultant role is evolving from benefits advisor to strategic partner in population health and long-term healthcare planning. That evolution requires partners who can support informed, forward-looking decision-making.
Accountability Will Define the Next Generation of Vendor Partnerships
The obesity market is crowded with engagement promises, marketing claims, and rapidly expanding point solutions. But employers are beginning to ask harder questions:
- Which outcomes are validated?
- What happens after the first year?
- How is success measured?
- Who shares accountability if the strategy underperforms?
This shift toward accountability is healthy for the market. It is also changing how consultants evaluate vendor partnerships.
Increasingly, employers and consultants are prioritizing organizations that demonstrate:
- An evidence-based approach
- Long-term engagement models
- Clinically proven outcomes
- Financial alignment
- Measurable ROI
- Shared-risk or performance-based approaches
- Long-term engagement models
The future obesity management market will reward partners that can prove sustainable value, not simply rapid adoption.
Increasingly, that accountability also includes how organizations define success, ensuring outcomes are evaluated not only through cost and utilization, but also through whether programs support equitable access, reduce bias in how weight and health are understood, and create environments where individuals can engage in sustainable, healthy behaviors. ange support = a better experience and more sustainability.
The Opportunity Ahead for Benefits Consultants
There is understandable anxiety around GLP-1 trendlines, rising pharmacy costs, and uncertain long-term utilization. But there is also a significant opportunity emerging for consultants willing to lead strategically instead of reacting tactically.
Obesity is no longer a fringe benefits conversation. It is rapidly becoming central to workforce health, productivity, chronic disease strategy, and financial planning.
This also requires recognizing that sustainable change is not solely about individual behavior, but about expanding access to evidence-based, weight-inclusive solutions that support metabolic health, behavior change, and whole-person well-being within the context of real-world constraints.
Consultants who can connect those dots, and help employers move beyond fragmented point solutions toward integrated, evidence-based approaches, will become increasingly valuable strategic partners to their clients.
That requires more than product recommendations.
It requires:
- Independent thinking
- Clinical credibility
- Long-term financial modeling
- Behavioral health expertise
- Cross-functional strategy
- Partners committed to accountability over hype
The Bottom Line
The GLP-1 era is forcing a broader reckoning in employer healthcare strategy.
The real question is no longer whether employers will address obesity more aggressively. It’s whether organizations will approach obesity as a temporary pharmacy trend or as a long-term population health challenge requiring sustainable behavioral, clinical, and financial strategies.
Benefits consultants have an opportunity to shape that future. The ones who lead with independence, evidence, and long-term thinking will not just help clients manage GLP-1 costs. They will help redefine what an effective obesity strategy looks like in the years ahead.
For consultants looking to bring greater rigor and predictability to obesity benefit strategy, Wondr Health offers Value Engine analyses that help model ROI, compare benefit scenarios, and quantify what smarter obesity and GLP-1 spend can look like for employers and health plans.
Connect with Patti Rittling, Head of Broker & Consultant Relations at Wondr Health, to explore how preventive intervention strategies can help clients manage today’s risks while building more sustainable long-term population health outcomes.
Patti brings more than 20 years of experience advising Fortune 500 employers on benefits, well-being, and population health strategy. Her work spans clinical science, employee health, and strategic consulting, with a focus on advancing evidence-based approaches that reduce weight stigma, promote equitable access to care, and support sustainable, health-forward behaviors. Before joining Wondr Health, she held senior roles at TELUS Health, Mercer, and Marsh & McLennan Agency, partnering with employers and consultants to design data-driven strategies that improve workforce well-being and business outcomes.
